Silver Book Fact

A clinical trial in Europe found that treating Alzheimer’s patients with an Alzheimer’s drug reduced annual treatment costs by $1,000 per patient.

PhRMA Japan. Aricept Reduces Annual Treatment Cost by $1,000 Per Patient: Pfizer; 10-Sep-2000

Reference

Title
Aricept Reduces Annual Treatment Cost by $1,000 Per Patient: Pfizer
Publication Date
10-Sep-2000
Authors
PhRMA Japan

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • A $1 billion-investment in Alzheimer’s research that led to research breakthroughs by 2010 could have a 10-to-1 return by 2015, and a 90-to-1 return by 2050.  
  • Stem Cell Therapy Study Shows Improved Motor Function in Parkinson’s
     
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2050 Medicare costs for people with the disease would be…  
  • Donepezil, a cholinesterase inhibitor, has been found to slow progression of Alzheimer’s disease in its early stages, delaying the need for nursing home care by an average of 30 months.  
  • Medicines Allow Patients to Remain Independent Longer: New Alzheimer’s medicine delays need for costly home care